ArticlePhotochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology2026
Azure A as a promising candidate for antimicrobial photodynamic therapy of acne-related bacteria.
Article in Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Light-driven bacterial inactivation using Plumeria rubra extract: a promising natural photosensitizer.International microbiology : the official journal of the Spanish Society for Microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial photodynamic inactivation (aPDT) is an effective technique for treating acne vulgaris, due to its efficiency in inactivating multiresistant bacteria and the absence of systemic side effects. This study investigated the potential of the dye Azure A (AZA), belonging to the phenothiazine class, as a photosensitizer (PS) in aPDT to combat the gram-positive bacteria Staphylococcus epidermidis and Cutibacterium acnes, both associated with inflammatory acne vulgaris. The efficiency of AZA was compared to Orthotoluidine Blue (OTB), evaluating the absorbance spectra, singlet oxygen generation rate, and minimum bactericidal concentration (MBC) at different optical fluence values and concentrations. The results demonstrated that AZA and OTB have similar spectroscopic characteristics and single oxygen generation rates, and they could inactivate both bacteria at an MBC of 0.78 [Formula: see text] for the smallest tested optical fluence. These findings indicate that AZA is an excellent candidate for topical aPDT applications in treating acne vulgaris and other associated infections by such bacteria.
Indexed as
Identifiers
41678115What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.